<DOC>
	<DOC>NCT02104414</DOC>
	<brief_summary>The purpose of this study is to compare the quality and duration of pain relief after a hemorrhoidectomy, provided by locally administered liposomal bupivacaine versus bupivacaine hcl or control with saline. It is hypothesized that liposomal bupivacaine will provide more effective postoperative pain relief than both bupivacaine hcl and the control.</brief_summary>
	<brief_title>Efficacy of Rectal Infiltration of Exparel for Analgesic Benefit Following Hemorrhoidectomy</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhoids</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<criteria>patients undergoing hemorrhoidectomy for grade 3 or 4 hemorrhoids who are Englishspeaking patients, 2165 yr of age, ASA physical status IIII, BMI&lt;30 contraindications to administration of local anesthesia (e.g., local anesthetic allergy), difficult airway (Mallampati&gt;2), psychiatric or cognitive disorders, pregnancy , and history of substance abuse or chronic opioid use</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Liposomal Bupivacaine</keyword>
	<keyword>Exparel</keyword>
</DOC>